000 01447nas a2200349 i 4500
001 EDZ0002387311
003 StDuBDS
005 20250228152236.0
006 m||||fo||j||||||||
007 cr||||||||||||
008 201126c20209999enk|| p|o|||| 0 |2eng|d
022 _a2732-4303
040 _aStDuBDS
_beng
_cStDuBDS
_erda
_epn
050 4 _aRM270
082 0 4 _a616.07905
_223
245 0 0 _aImmunotherapy advances /
_ceditor-in-chief, Professor Tim Elliott, FRSB, FMedSci.
264 3 1 _aOxford :
_bOxford University Press,
_c2020-
300 _a1 online resource
310 _aFrequency of update unknown
336 _atext
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
362 1 _a2020-
500 _a"British Society for Immunology"--Home page.
506 0 _aOpen access.
520 8 _a'Immunotherapy Advances' is a fully Open Access peer-reviewed journal brought to you by the British Society for Immunology and edited by world leading immunologist Professor Tim Elliott, supported by a global editorial board of experts from academia and industry.
588 _aDescription based on online resource; title from home page (viewed on November 26, 2020).
650 0 _aImmunotherapy
_xResearch
_vPeriodicals.
700 1 _aElliott, Tim,
_eeditor.
710 2 _aBritish Society for Immunology,
_eassociated with work.
856 4 0 _3Oxford journals
_uhttp://academic.oup.com/immunotherapyadv
999 _c20055
_d20055